BioCentury
ARTICLE | Company News

KaloBios cancer news

January 4, 2016 8:00 AM UTC

KaloBios filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. Earlier in December, the company received a letter from NASDAQ advising that the exchange had determined to delist KaloBios shares. NASDAQ cited a number of reasons for the decision, including the recent criminal indictment and arrest of Martin Shkreli, KaloBios' controlling shareholder and former chairman and CEO, on securities fraud charges. The company subsequently submitted a request to appeal NASDAQ's decision, and a hearing has been scheduled for Feb. 25. ...